Peptide & Compound Guide
At a glance
| Compound | TB-500 |
|---|---|
| Type | Thymosin-beta-4-related research peptide |
| U.S. regulatory context | Not FDA approved |
| Evidence level | Primarily preclinical / investigational |
| Research area | Cell migration, tissue repair and recovery research |
What is TB-500?
TB-500 is a name used for peptide material related to thymosin beta-4 research. It is commonly promoted for recovery, but promotional claims often go beyond available human evidence.
What does the research examine?
Thymosin beta-4 biology has been studied in wound healing, cell migration and tissue processes. That does not establish that commercial TB-500 products are safe or effective for human treatment.
What has not been established?
Mechanism, biomarker changes, animal findings and early clinical signals are not the same as proof that a compound safely improves meaningful health outcomes. Claims should be matched to the type, size and quality of evidence available.
Safety and regulatory context
Competitive athletes should also verify current anti-doping rules before considering any substance in this category.
Related: BPC-157 vs. TB-500
Research sources
Use primary and authoritative sources when evaluating claims about this compound. Search results can change as new research is published.